CanaQuest Medical Corp. (CANQF)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

Aug 21, 2026, 4:00 PM EST

-99.48% (1Y)

Market Cap	21.00 -100.0%
Revenue (ttm)	n/a
Net Income	-853.85K
EPS	-0.06
Shares Out	21.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	361,550
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0140
Beta	-0.43
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CanaQuest Medical

CanaQuest Medical Corp. develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils. The company was formerly known as Algae Dynamics Corp. and changed its name to CanaQuest Medical Corp. in January 2019. CanaQuest Medical Corp. was founded in 2008 and is based in Mississauga, Canada. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2008

Country Canada

Stock Exchange OTCMKTS

Ticker Symbol CANQF

Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program

TORONTO, ON / ACCESSWIRE / July 26, 2023 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest "), a clinical-stage life sciences company focused on drug discovery and development of ...

3 years ago - Accesswire

CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine(R)

TORONTO, ON / ACCESSWIRE / April 25, 2023 / CANAQUEST MEDICAL CORP. (OTC PINK:CANQF) (the "Company" or "CanaQuest "), a clinical-stage life sciences company focused on drug discovery and development o...

3 years ago - Accesswire

CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD

Drug Candidate, CQ-001 (cannabidiol "CBD" + IP formula), also demonstrated substantially reduced seizures at higher doses, with less CBD, compared to standard CBD. TORONTO, ON / ACCESSWIRE / December ...

4 years ago - Accesswire

Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD

USERS REPORT INCREASED MENTAL CLARITY, BETTER SLEEP, MORE ENERGY, AND LESS BRAIN FOG AND JOINT STIFFNESS TORONTO, ON / ACCESSWIRE / September 8, 2022 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Co...